Lower Urinary Tract Symptoms
250
26
33
143
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
26 trials with published results (10%)
Research Maturity
143 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
11 terminated out of 250 trials
92.9%
+6.4% vs benchmark
11%
27 trials in Phase 3/4
18%
26 of 143 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 143 completed trials
Clinical Trials (250)
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Core Massage and Exercise in Pediatric LUTD
BPH Global Registry
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.
Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial
A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
Double j Stent Related Symptoms
INTIBIA Pivotal Study
RADA16 for Aquablation Day Case
Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .
LURN: Urinary Urgency Phenotyping Protocol
Neuflo System for the Treatment of BPH
Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD
Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly
Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH
Intermittent vs Daily Tamsulosin for LUTS/BPH
Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
US Imaging for the Assessment of LUTS